HTG Molecular Diagnostics, Inc. Stock
Stocks
HTGMQ
US40434H3021
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
18:08:37 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
0.00% | - |
| 21/05/25 | Motion For Case Conversion Approved for HTG Molecular Diagnostics, Inc. | CI |
| 28/04/25 | Motion for Case Conversion Filed by HTG Molecular Diagnostics, Inc. | CI |
| Market Cap | 2.88K 2.48K 2.34K 2.13K 4K 273K 4.02K 27.61K 10.75K 139K 10.81K 10.57K 461K | P/E 2021 |
-2.19x | P/E 2022 | -0.16x |
|---|---|---|---|---|---|
| Enterprise Value | -3.41M -2.94M -2.77M -2.52M -4.74M -324M -4.76M -32.7M -12.73M -165M -12.8M -12.52M -546M | EV / Sales 2021 |
3.96x | EV / Sales 2022 | 0.04x |
| Free-Float |
99.86% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -99.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.4 |
| 5 years | 0 | | 80.76 |
| 10 years | 0 | | 2,385 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/06/23 | Sell | Senior VP of Therapeutics | 888 | 0.0401% | ||
| 31/03/23 | Tax | Senior VP of Therapeutics | 52 | 0.0056% | - | |
| 02/02/23 | Other | Senior VP of Therapeutics | 7,610 | 0.8264% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.00% | 0.00% | - | - | 221 | |
| -0.80% | +0.28% | +21.47% | -33.35% | 17.93B | |
| -0.44% | -7.58% | -36.42% | +54.88% | 1.6B | |
| -4.71% | -8.64% | -52.07% | -83.56% | 990M | |
| +0.38% | -0.91% | -24.42% | +19.74% | 946M | |
| -0.11% | -0.16% | +59.91% | -7.37% | 779M | |
| +2.40% | +0.09% | -33.29% | -45.77% | 673M | |
| +2.07% | +12.34% | -37.01% | -47.63% | 598M | |
| +8.97% | +10.15% | -32.59% | -30.90% | 462M | |
| -0.19% | -3.18% | +70.40% | +49.79% | 441M | |
| Average | -9.14% | -0.71% | -7.11% | -13.80% | 2.44B | |
| Weighted average by Cap. | -0.51% | -0.35% | +11.07% | -25.86% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 8.91M 7.68M 7.23M 6.58M 12.38M 845M 12.45M 85.44M 33.25M 430M 33.44M 32.72M 1.43B | 6.37M 5.49M 5.17M 4.71M 8.85M 604M 8.9M 61.07M 23.77M 307M 23.9M 23.38M 1.02B |
| Net income | -17.15M -14.79M -13.91M -12.67M -23.83M -1.63B -23.96M -164M -64.01M -828M -64.37M -62.98M -2.74B | -21.59M -18.63M -17.52M -15.96M -30.02M -2.05B -30.18M -207M -80.63M -1.04B -81.08M -79.32M -3.46B |
| Net Debt | -5.74M -4.95M -4.65M -4.24M -7.97M -544M -8.02M -55.03M -21.42M -277M -21.54M -21.07M -918M | -3.41M -2.94M -2.77M -2.52M -4.74M -324M -4.77M -32.73M -12.74M -165M -12.81M -12.53M -546M |
Employees
54
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- HTGMQ Stock
Select your edition
All financial news and data tailored to specific country editions
